Connect Biopharma Holdings Limited (Nasdaq: CNTB) announced the completion of enrollment in its Phase 2 Seabreeze STAT Asthma study, which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE